- Home
- GH vs BBAR Comparison
GH vs BBAR Comparison
Compare GH & BBAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- BBAR
- Stock Information
- Founded
- GH 2011
- BBAR 1886
- Country
- GH United States
- BBAR Argentina
- Employees
- GH N/A
- BBAR N/A
- Industry
- GH Medical Specialities
- BBAR Commercial Banks
- Sector
- GH Health Care
- BBAR Finance
- Exchange
- GH Nasdaq
- BBAR Nasdaq
- Market Cap
- GH 4.3B
- BBAR 3.6B
- IPO Year
- GH 2018
- BBAR N/A
- Fundamental
- Price
- GH $31.83
- BBAR $18.30
- Analyst Decision
- GH Strong Buy
- BBAR Buy
- Analyst Count
- GH 14
- BBAR 1
- Target Price
- GH $39.93
- BBAR $27.00
- AVG Volume (30 Days)
- GH 1.6M
- BBAR 836.1K
- Earning Date
- GH 11-06-2024
- BBAR 11-20-2024
- Dividend Yield
- GH N/A
- BBAR 8.43%
- EPS Growth
- GH N/A
- BBAR N/A
- EPS
- GH N/A
- BBAR 0.34
- Revenue
- GH $692,256,000.00
- BBAR $2,185,985,032.00
- Revenue This Year
- GH $32.23
- BBAR N/A
- Revenue Next Year
- GH $16.90
- BBAR N/A
- P/E Ratio
- GH N/A
- BBAR $19.92
- Revenue Growth
- GH 29.20
- BBAR N/A
- 52 Week Low
- GH $15.81
- BBAR $4.63
- 52 Week High
- GH $38.53
- BBAR $19.98
- Technical
- Relative Strength Index (RSI)
- GH 45.64
- BBAR 58.61
- Support Level
- GH $34.20
- BBAR $16.80
- Resistance Level
- GH $36.24
- BBAR $19.98
- Average True Range (ATR)
- GH 1.70
- BBAR 1.31
- MACD
- GH -0.92
- BBAR -0.07
- Stochastic Oscillator
- GH 15.98
- BBAR 57.14
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focused on foreign trade, agricultural business, and digital products.